Poor-Quality and Counterfeit Drugs: A Systematic Assessment of Prevalence and Risks Based on Data Published From 2007 to 2016-Reference-Cited by-同舟云学术

Poor-Quality and Counterfeit Drugs: A Systematic Assessment of Prevalence and Risks Based on Data Published From 2007 to 2016

Published:2017-10 Issue:10 Volume:106 Page:2921-2929
ISSN:0022-3549
Container-title:Journal of Pharmaceutical Sciences
language:en
Short-container-title:Journal of Pharmaceutical Sciences

Author:

Koczwara Andreas,Dressman Jennifer

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference80 articles.

1. Keeping it Real. Combating the Spread of Fake Drugs in Poor Countries;Harris,2009

2. Counterfeit or substandard antimicrobial drugs: a review of the scientific evidence;Kelesidis;J Antimicrob Chemother,2007

3. Assessment of the incidence of substandard drugs in developing countries;Shakoor;Trop Med Int Health,1997

4. Counterfeit Drugs. Guidelines for the Development of Measures to Combat Counterfeit Drugs,1999

5. Pharmaceutical Security Institute. Counterfeit Situation. Available at: http://www.psi-inc.org/counterfeitSituation.cfm. Accessed January 26, 2016.

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In vitro comparative quality assessment of different brands of hydrochlorothiazide tablets marketed in Northeast Ethiopia;Frontiers in Analytical Science;2024-07-30

2. Research landscape analysis for quality in Pharma 4.0 era;Technology in Society;2024-03

3. Improving access to medicines to reduce marketing and use of substandard and falsified medicines in Africa: Scoping review;The Journal of Medicine Access;2024-01

4. SUBJECTIVE ANALYSIS OF QUALITY INDICATORS OF MEDICINAL PRODUCTS;Актуальні проблеми сучасної медицини: Вісник Української медичної стоматологічної академії;2023-12-20

5. Four decades of counterfeit research: A bibliometric analysis;Cogent Business & Management;2023-11-27